ArticleExperimental and therapeutic medicine2026
Sotagliflozin ameliorates doxorubicin-induced cardiomyopathy by regulating inflammation and mitochondrial dysfunction through the AMPK/mTOR pathway.
Haifeng Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.